Search research articles
Contact Us
Filters
Showing results (171-180 of 250) with videos related to
Page
of 25
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
November 22, 2012
Low-affinity B cells transport viral particles from the lung to the spleen to initiate antibody responses
Juliana Bessa, Franziska Zabel, Alexander Link, et al.
Allergy
|
November 8, 2018
Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses
Antonia Fettelschoss-Gabriel, Victoria Fettelschoss, Florian Olomski, et al.
The Journal of Allergy and Clinical Immunology
|
December 14, 2020
Glycan-specific IgG anti-IgE autoantibodies are protective against allergic anaphylaxis in a murine model
Paul Engeroff, Kevin Plattner, Federico Storni, et al.
Vaccines
|
May 28, 2022
Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron
Anne-Cathrine S Vogt, Gilles Augusto, Byron Martina, et al.
European Journal of Immunology
|
October 31, 2009
Innate signaling regulates cross-priming at the level of DC licensing and not antigen presentation
Susanne A Keller, Katrin Schwarz, Vania Manolova, et al.
Frontiers in Immunology
|
July 5, 2022
Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies
Anne-Cathrine S Vogt, Lukas Jörg, Byron Martina, et al.
Science (New York, N.Y.)
|
August 4, 2007
Regulation of homeostatic chemokine expression and cell trafficking during immune responses
Scott N Mueller, Karoline A Hosiawa-Meagher, Bogumila T Konieczny, et al.
Veterinary Research
|
July 2, 2025
A bacteriophage-based virus-like particle vaccine induces cross-reactive neutralising antibodies against porcine epidemic diarrhoea viruses (PEDV)
Jixiang Gu, Xu Zheng, Chunhui Li, et al.
Viruses
|
September 27, 2025
Versatile and Scalable Nanoparticle Vaccine as a Scaffold Against Newly Emerging Influenza Viruses
Alessandro Pardini, Dominik A Rothen, Pascal S Krenger, et al.
Iscience
|
March 25, 2024
A tetravalent nanovaccine that inhibits growth of HPV-associated head and neck carcinoma via dendritic and T cell activation
Romano Josi, Daniel E Speiser, Simone de Brot, et al.
Page
of 25
Search research articles
Search
Showing results (171-180 of 250) with videos related to
Sort By:
Page
of 25
Proceedings of the National Academy of Sciences of the United States of America
|
November 22, 2012
Low-affinity B cells transport viral particles from the lung to the spleen to initiate antibody responses
Juliana Bessa, Franziska Zabel, Alexander Link, et al.
Allergy
|
November 8, 2018
Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses
Antonia Fettelschoss-Gabriel, Victoria Fettelschoss, Florian Olomski, et al.
The Journal of Allergy and Clinical Immunology
|
December 14, 2020
Glycan-specific IgG anti-IgE autoantibodies are protective against allergic anaphylaxis in a murine model
Paul Engeroff, Kevin Plattner, Federico Storni, et al.
Vaccines
|
May 28, 2022
Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron
Anne-Cathrine S Vogt, Gilles Augusto, Byron Martina, et al.
European Journal of Immunology
|
October 31, 2009
Innate signaling regulates cross-priming at the level of DC licensing and not antigen presentation
Susanne A Keller, Katrin Schwarz, Vania Manolova, et al.
Frontiers in Immunology
|
July 5, 2022
Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies
Anne-Cathrine S Vogt, Lukas Jörg, Byron Martina, et al.
Science (New York, N.Y.)
|
August 4, 2007
Regulation of homeostatic chemokine expression and cell trafficking during immune responses
Scott N Mueller, Karoline A Hosiawa-Meagher, Bogumila T Konieczny, et al.
Veterinary Research
|
July 2, 2025
A bacteriophage-based virus-like particle vaccine induces cross-reactive neutralising antibodies against porcine epidemic diarrhoea viruses (PEDV)
Jixiang Gu, Xu Zheng, Chunhui Li, et al.
Viruses
|
September 27, 2025
Versatile and Scalable Nanoparticle Vaccine as a Scaffold Against Newly Emerging Influenza Viruses
Alessandro Pardini, Dominik A Rothen, Pascal S Krenger, et al.
Iscience
|
March 25, 2024
A tetravalent nanovaccine that inhibits growth of HPV-associated head and neck carcinoma via dendritic and T cell activation
Romano Josi, Daniel E Speiser, Simone de Brot, et al.
Page
of 25